Genexa produces cleaner, effective over-the-counter medicines across traditional categories including pain and fever, cold and flu, digestion and allergy, with formulations for infants, kids and adults. The company emphasizes formulations without common inactive ingredients—its “Ex List” excludes sorbitol, propylene glycol, artificial dyes, synthetic binders, talc, gluten and lactose. Genexa says its innovative, patented preservative system allows shelf stability without artificial binders. Products are sold at over 45,000 retailers nationwide including Walmart, Target, CVS, Kroger, Walgreens, Whole Foods and Sprouts, and online at Genexa.com and Amazon. All products are manufactured according to FDA guidelines, are Non-GMO Project Verified and gluten-free; many are certified organic and vegan, and the company is a Certified B‑Corporation. Founded by David Johnson and Max Spielberg, Genexa intends to use its position and new capital to advance market leadership and accelerate a category shift toward cleaner OTC medicines.

Total raised

$60M

Funding rounds

1

Latest round

Series A

Latest activity

Jul 2021